MARKET

TARO

TARO

Taro Pharm
NYSE

Real-time Quotes | Nasdaq Last Sale

63.20
+0.80
+1.28%
Closed 16:00 04/03 EDT
OPEN
62.50
PREV CLOSE
62.40
HIGH
63.60
LOW
61.93
VOLUME
30.00K
TURNOVER
--
52 WEEK HIGH
109.42
52 WEEK LOW
56.07
MARKET CAP
2.44B
P/E (TTM)
9.80
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TARO stock price target is 94.00 with a high estimate of 94.00 and a low estimate of 94.00.

EPS

TARO News

More
  • Ranitidine products to be removed from U.S. market - FDA
  • Seeking Alpha - Article · 4d ago
  • Hedge Funds Were Buying Taro Pharmaceutical Industries Ltd. (TARO) Before The Coronavirus
  • Insider Monkey · 03/27 14:46
  • How Taro Pharmaceutical Industries Ltd. (NYSE:TARO) Can Impact Your Portfolio Volatility
  • Simply Wall St. · 03/22 15:35
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38

Industry

Pharmaceuticals
-0.13%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About TARO

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
More

Webull offers kinds of Taro Pharmaceutical Industries Ltd. stock information, including NYSE:TARO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TARO stock news, and many more online research tools to help you make informed decisions.